296 related articles for article (PubMed ID: 21679091)
1. Sodium oxybate for the treatment of fibromyalgia.
Staud R
Expert Opin Pharmacother; 2011 Aug; 12(11):1789-98. PubMed ID: 21679091
[TBL] [Abstract][Full Text] [Related]
2. Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: results from a 14-week, randomized, double-blind, placebo-controlled study.
Russell JI; Holman AJ; Swick TJ; Alvarez-Horine S; Wang GY; Guinta D;
Pain; 2011 May; 152(5):1007-1017. PubMed ID: 21397402
[TBL] [Abstract][Full Text] [Related]
3. Effects of sodium oxybate on sleep physiology and sleep/wake-related symptoms in patients with fibromyalgia syndrome: a double-blind, randomized, placebo-controlled study.
Moldofsky H; Inhaber NH; Guinta DR; Alvarez-Horine SB
J Rheumatol; 2010 Oct; 37(10):2156-66. PubMed ID: 20682669
[TBL] [Abstract][Full Text] [Related]
4. Once-nightly sodium oxybate (FT218) improved symptoms of disrupted nighttime sleep in people with narcolepsy: a plain language summary.
Roth T; Thorpy MJ; Kushida CA; Horsnell M; Gudeman J
J Comp Eff Res; 2023 Dec; 12(12):e230133. PubMed ID: 37971303
[TBL] [Abstract][Full Text] [Related]
5. The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia.
Scharf MB; Baumann M; Berkowitz DV
J Rheumatol; 2003 May; 30(5):1070-4. PubMed ID: 12734908
[TBL] [Abstract][Full Text] [Related]
6. Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trial.
Spaeth M; Bennett RM; Benson BA; Wang YG; Lai C; Choy EH
Ann Rheum Dis; 2012 Jun; 71(6):935-42. PubMed ID: 22294641
[TBL] [Abstract][Full Text] [Related]
7. Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary.
Rosenberg R; Braceras R; Macfadden W; Candler S; Black J; Ruoff C
Neurol Ther; 2023 Dec; 12(6):1805-1820. PubMed ID: 37755650
[TBL] [Abstract][Full Text] [Related]
8. gamma-Hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulness.
Pardi D; Black J
CNS Drugs; 2006; 20(12):993-1018. PubMed ID: 17140279
[TBL] [Abstract][Full Text] [Related]
9. Effect of sodium oxybate on growth hormone secretion in narcolepsy patients and healthy controls.
Donjacour CE; Aziz NA; Roelfsema F; Frölich M; Overeem S; Lammers GJ; Pijl H
Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1069-75. PubMed ID: 21447786
[TBL] [Abstract][Full Text] [Related]
10. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
Black J; Pardi D; Hornfeldt CS; Inhaber N
Sleep Med; 2009 Sep; 10(8):829-35. PubMed ID: 19616998
[TBL] [Abstract][Full Text] [Related]
11. Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia.
Spaeth M; Alegre C; Perrot S; Wang Y; Guinta DR; Alvarez-Horine S; Russell I;
Arthritis Res Ther; 2013 Nov; 15(6):R185. PubMed ID: 24286114
[TBL] [Abstract][Full Text] [Related]
12. Effect of gamma-hydroxybutyrate on pain, fatigue, and the alpha sleep anomaly in patients with fibromyalgia. Preliminary report.
Scharf MB; Hauck M; Stover R; McDannold M; Berkowitz D
J Rheumatol; 1998 Oct; 25(10):1986-90. PubMed ID: 9779855
[TBL] [Abstract][Full Text] [Related]
13. Sodium oxybate: new drug. Fewer attacks of cataplexy in some patients.
Prescrire Int; 2007 Jun; 16(89):98-101. PubMed ID: 17582923
[TBL] [Abstract][Full Text] [Related]
14. Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial.
Russell IJ; Perkins AT; Michalek JE;
Arthritis Rheum; 2009 Jan; 60(1):299-309. PubMed ID: 19116896
[TBL] [Abstract][Full Text] [Related]
15. A 12-week open-label, multicenter study evaluating the safety and patient-reported efficacy of sodium oxybate in patients with narcolepsy and cataplexy.
Mamelak M; Swick T; Emsellem H; Montplaisir J; Lai C; Black J
Sleep Med; 2015 Jan; 16(1):52-8. PubMed ID: 25533539
[TBL] [Abstract][Full Text] [Related]
16. A 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndrome.
George CF; Feldman N; Zheng Y; Steininger TL; Grzeschik SM; Lai C; Inhaber N
Sleep Breath; 2011 Jan; 15(1):13-20. PubMed ID: 20082240
[TBL] [Abstract][Full Text] [Related]
17. Clinical perspective: monitoring sodium oxybate-treated narcolepsy patients for the development of sleep-disordered breathing.
Feldman NT
Sleep Breath; 2010 Feb; 14(1):77-9. PubMed ID: 19626356
[TBL] [Abstract][Full Text] [Related]
18. The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy.
Black J; Pardi D; Hornfeldt CS; Inhaber N
J Clin Sleep Med; 2010 Dec; 6(6):596-602. PubMed ID: 21206549
[TBL] [Abstract][Full Text] [Related]
19. Randomized, crossover, open-label study of the relative bioavailability and safety of FT218, a once-nightly sodium oxybate formulation: Phase 1 study in healthy volunteers.
Bogan R; Thorpy MJ; Winkelman JW; Dubow J; Gudeman J; Seiden D
Sleep Med; 2022 Dec; 100():442-447. PubMed ID: 36252412
[TBL] [Abstract][Full Text] [Related]
20. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.
Black J; Swick T; Bogan R; Lai C; Carter LP
Sleep Med; 2016 Aug; 24():57-62. PubMed ID: 27810187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
